Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Adjuvant Immunotherapy and Radiotherapy for Resectable Squamous, Adeno or Large Cell Lung Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7718


2.		Surgery and Adjuvant Immunotherapy with BCG and Levamisole for Completely Resected non-Small Cell Cancer of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								WA-LUN-1 NOG-2177

Last Modified: 5/16/2006


3.		Phase III Adjuvant BCG/INH/LEV Immunotherapy vs CAP-I (CTX/ADR/CACP) for Stage II/III Large Cell and Adenocarcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								LCSG-772


4.		Phase III Comparative Studies of Immunotherapy with BCG and INH, Chemotherapy with MTX, Radiotherapy, and Surgery for Disseminated Cancer of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MI-HN-1


5.		Phase III Immunotherapy with BCG for Stage I/II/III Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MI-LUN-1


6.		Phase III Immunotherapy with BCG for Stage I Resected non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NY-LUN-1 NCI-C76-164

Last Modified: 7/20/2007


7.		Phase III Intradermal BCG plus Nontumorigenic Autologous Cancer Cells for Resected Stage II/III Lung and Esophageal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								NCI-C83-0695 C83-0695

Last Modified: 8/14/2007


8.		Phase III Randomized Study of Intravesicular EPI vs BCG vs BCG/INH in Patients with pTa/pT1 Papillary Carcinoma of the Urinary Bladder at Intermediate or High Risk of Recurrence

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				18 to 85								EORTC-30911

Last Modified: 10/1/1997


9.		Phase II Pilot Immunotherapy with Intraperitoneal BCG plus Melphalan/Isoniazid Chemotherapy for Stage IC, II or III Ovarian Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				EST-PE-878


10.		Prospective LEV/Radiation vs LEV/BCG/Radiation vs Radiation Alone for Advanced non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Closed				no age specified								NCI-D78-006-225 YALE-1683

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute